Pricing

Log inSign up

NeuroSense Therapeutics

0 followers

‌

NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.

Industries

Biotechnology

Headquarters

Herzliya, Israel

Employees

11-50

Links

Org chart

Alon Ben-Noon
Co-Founder & CEO

Alon Ben-Noon

Collapse
Or Eisenberg
CFO
Ferenc Tracik
CMO
Oron Yacoby-Zeevi
Chief Scientific Officer
Sharon Cohen Vered
VP, CMC
Niva Russek-Blum
VP, Discovery & IP Generator
Hagit Binder
VP, Operations
Nedira Salzman-Frenkel
VP, Business Development
Diana Shtossel
Head of Regulatory Affairs
Keren Pushett
Head of HR
Vered Sasson
Lead CRA

Board & advisors

Mark Leuchtenberger
Chairman, Board of Directors
Cary Claiborne
Member Board Of Directors; Audit Committee Chair
Christine Pellizzari
Board Member
Jeremy Shefner
Scientific Advisor
Merit Cudkowicz
Scientific Advisor
Jinsy Andrews
Scientific Advisor
Orla Hardiman
Scientific Advisor
Revital Mandil-Levin
Advisor
Yossi Gilgun-Sherki
Advisor
Jeffrey Rosenfeld
Scientific Advisory Board Member

Teams

+5

Scientific Roles

8 members

+2

Board Governance

5 members

+3

Leadership Team

6 members

+1

Business Operations

4 members

+1

Regulatory Affairs

4 members

Offices

Similar companies

Tessera Therapeutics

2 followers

Pyxis Oncology

2 followers

IO Biotech

2 followers

Brightseed

2 followers

Obsidian Therapeutics

1 follower

Apogee Therapeutics

1 follower

Cargo

1 follower

Cue Biopharma

1 follower

BioLamina

1 follower

Anthos Therapeutics

1 follower

Entact Bio

1 follower

Explore companies